Patient centricity vs. Profitability – why commercial innovation is key

Enter your details on the right to download your copy of the whitepaper

Beyond a few organisations where entire teams and roles have been created around the pursuit of true ‘patient centricity’, some of pharma’s most important customer-facing functions are unclear on the necessary steps needed to be worthy of the title ‘patient-centric’ – and even whether or not it should be their objective at all.

Highlights of the whitepaper include:

  • Can patient-centricity and profitability co-exist? We have the answer.
  • We ask industry experts about finding the ‘sweet spot’ where there can be both patient focus and business focus – and the needs of both are met.
  • Pharma have confidence in the commercial benefits of patient focus, but lack the confidence to take things to the next level. We explore what is needed to make this happen.
  • How to make patient focus and business focus real – through budget, measurement, and training.
  • Concrete examples of the role of patient focus on profitability

Key Contributors:

  • Christi Shaw, former U.S. Country Head and President, Novartis Pharmaceuticals Corporation
  • Ramona Sequeira, President, Takeda Pharmaceutical Company Ltd
  • John Gerow, Service Team Strategy Partner, Ashfield & Principle, JG Consulting Inc.
  • Deborah Waterhouse, SVP and Business Unit Head UD Primary Care, GSK
  • Jens Lipinski, Head of Patient Relations, Bayer Healthcare

Enter your details on the right to download your copy of the whitepaper

Nicky

Nicky Williams
Global Project Director | eyeforpharma
nwilliams@eyeforpharma.com
(+44) 020 7375 7225
eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditions

Fill out your details below to receive your copy of the whitepaper

Whitepaper Download